Relx Plc $RELX Shares Purchased by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC boosted its stake in Relx Plc (NYSE:RELXFree Report) by 697.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 159,681 shares of the technology company’s stock after buying an additional 139,663 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Relx were worth $5,306,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of RELX. Capital International Investors boosted its stake in shares of Relx by 66.7% in the fourth quarter. Capital International Investors now owns 10,662,595 shares of the technology company’s stock worth $433,887,000 after acquiring an additional 4,264,474 shares during the last quarter. Morgan Stanley lifted its stake in shares of Relx by 7.0% in the fourth quarter. Morgan Stanley now owns 6,279,696 shares of the technology company’s stock worth $253,825,000 after buying an additional 408,833 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Relx by 1.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,502,488 shares of the technology company’s stock worth $141,583,000 after acquiring an additional 56,363 shares during the last quarter. Ameriprise Financial Inc. boosted its position in Relx by 1.4% during the third quarter. Ameriprise Financial Inc. now owns 3,390,649 shares of the technology company’s stock worth $164,120,000 after acquiring an additional 46,515 shares during the last quarter. Finally, Northern Trust Corp grew its stake in Relx by 3.5% during the 3rd quarter. Northern Trust Corp now owns 2,430,755 shares of the technology company’s stock valued at $116,093,000 after acquiring an additional 81,195 shares in the last quarter. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Morgan Stanley downgraded shares of Relx from an “overweight” rating to an “equal weight” rating in a report on Thursday, May 7th. Weiss Ratings raised Relx from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, July 6th. The Goldman Sachs Group began coverage on Relx in a research report on Wednesday, June 3rd. They set a “buy” rating on the stock. Citigroup raised Relx from a “neutral” rating to a “buy” rating in a research note on Wednesday, April 8th. Finally, Wall Street Zen lowered Relx from a “buy” rating to a “hold” rating in a report on Sunday, May 17th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Relx has an average rating of “Moderate Buy”.

Check Out Our Latest Research Report on Relx

Relx Price Performance

Shares of Relx stock opened at $32.91 on Friday. Relx Plc has a 12 month low of $27.57 and a 12 month high of $54.02. The company has a debt-to-equity ratio of 2.38, a quick ratio of 0.44 and a current ratio of 0.49. The business has a 50-day moving average of $32.82 and a 200 day moving average of $34.23.

Relx (NYSE:RELXGet Free Report) last posted its quarterly earnings data on Thursday, July 23rd. The technology company reported $45.44 EPS for the quarter, beating the consensus estimate of $0.89 by $44.55. The business had revenue of $3.23 billion during the quarter, compared to analysts’ expectations of $6.54 billion. Equities analysts anticipate that Relx Plc will post 1.94 earnings per share for the current fiscal year.

Trending Headlines about Relx

Here are the key news stories impacting Relx this week:

Relx Profile

(Free Report)

RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.

RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.

See Also

Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELXFree Report).

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.